Conclusion
In conclusion, this literature review demonstrates that oral NMP and
NMP-SR are effective therapeutic options for managing women requiring
luteal phase support during ART treatment, for preventing miscarriage;
for preventing preterm birth, and for managing high-risk pregnancy. Both
conventional oral NMP and NMP-SR have the advantage of being natural
progesterone. NMP-SR provides additional benefits in terms of once-daily
dosing, which can facilitate patient compliance, and an improved
tolerability profile. Oral NMP-SR represents a valuable option in the
therapeutic armamentarium for treating obstetric conditions associated
with insufficient progesterone exposure.